Romuald Mentaverri

Has grant

Professor

Université de Picardie Jules Verne
Country flagFrance

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Romuald Mentaverri is a Professor at the University of Picardie Jules Verne in France. His research focuses on bone health in pediatric populations, chronic kidney disease, and vascular functions. Recent publications include studies on bone health in children with severe cerebral palsy and the relationship between bone marrow adipose tissue and kidney function in postmenopausal women. He is also investigating the effects of various treatments and conditions, including the impact of COVID-19 on endothelial function.

Recent Grants

Grant: Close

Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

Open Date: 2016-03-01

Close Date: 2020-02-29

Grant: Close

The role of the Calcium Sensing Receptor (CaSR) in health and disease, implications for translational medicine

Open Date: 2011-01-01

Close Date: 2014-12-31

Articles (10)

Background Rapid progression of aortic stenosis (AS) has been observed in patients undergoing dialysis, but existing cross-sectional evidence is contradictory in non-dialysis-dependent chronic kidney disease (CKD). The present study sought to evaluate whether CKD is associated with the progression of AS over time in a large cohort of patients with AS. Methods We retrospectively studied all consecutive patients diagnosed with AS [peak aortic jet velocity (Vmax) ≥2.5 m/s] and left ventricular ejection fraction ≥50% in the echocardiography laboratories of two tertiary centers between 2000 and 2018. The estimated glomerular filtration rate (eGFR) (mL/min/1.73 m2) was calculated from serum creatinine values. Patients were divided into five CKD stages according to the baseline eGFR. Annual rates of change in the aortic valve area (AVA) were determined by a linear mixed-effects model. Results Among the 647 patients included, 261 (40%) had CKD. After a median follow-up of 2.9 (interquartile range 1.8–4.8) years, the mean overall rate of change in AVA was –0.077 (95% confidence interval –0.082; –0.073) cm2/year. There was an inverse relationship between the progression rate and kidney function. The more severe the CKD stage, the greater the AVA narrowing (P < .001). By multivariable linear regression analysis, the eGFR was also negatively associated (P < .001) with AS progression. An eGFR strata below 45 mL/min/1.73 m2 was associated with higher odds of rapid progression of AS than normal kidney function. During the clinical follow-up, event-free survival (patients free of aortic valve replacement or death) decreased as CKD progressed. Rapid progression of AS in patients with kidney dysfunction was associated with worse outcomes. Conclusions Patients with CKD exhibit more rapid progression of AS over time and require close monitoring. The link between kidney dysfunction and rapid progression of AS is still unknown and requires further research.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Florelle Gindraux

Université de Franche-Comté

FRANCE
View details

Vincent Goeb

Professor of Rheumatology, Head of Department

Université de Picardie Jules Verne

FRANCE
View details

Julien Paccou

-

FRANCE
View details

Olivier Bourron

Sorbonne Université

FRANCE
View details

Catherine Chaussain

Prof

Université Paris Cité

FRANCE
View details

Isabelle Six

-

FRANCE
View details

Christophe Tribouilloy

-

FRANCE
View details

Caroline Andrique

Associate professor

Université Paris Descartes

FRANCE
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.